Colgate-Palmolive Company (CL)
Colgate-Palmolive Sales Rise as Higher Prices Offset Lower Volumes
Colgate-Palmolive said sales rose in the third quarter, as higher prices offset a decline in volumes.
Colgate's Pre-Q3 Earnings: Will Pricing Actions Offset Cost Headwinds?
CL's Q3 results are likely to reveal how pricing strength and productivity gains help offset inflation, currency pressures and regional softness.
Colgate-Palmolive: 2 Reasons Why The Share Price Drop Has Gone Too Far (Upgrade)
Colgate-Palmolive stock has fallen by nearly 20% over the past year, and this is raising questions regarding market expectations. It seems that the market is pricing in an adverse scenario for margins that is highly unlikely. The current dividend yield does not seem to suggest that CL is undervalued, but there are indications of more notable dividend hikes in the future.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Oversold Conditions For Colgate-Palmolive
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend King Down 26% to Buy Right Now
First things first, most Dividend Kings (stocks that have increased dividends for at least 50 years in a row) won't provide investors with multibagger returns anytime soon.
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
CL powers growth with pricing strength, cost savings, premium innovation and AI-driven supply-chain agility.
Buy CL Stock At $80?
Colgate-Palmolive stock (NYSE: CL) has decreased by 12% this year, lagging behind the S&P 500, which has risen by 13%. This drop is primarily attributed to various factors, such as slowing sales growth, with the company projecting only about 2% organic sales growth for 2025.
Colgate-Palmolive: A Defensive Staple With Meaningful Upside
Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation, and a 62-year dividend growth streak. CL demonstrates resilience amid inflation, with robust margins, an improving debt profile, and potential for further growth in emerging markets and sustainable products. DCF analysis and analyst consensus suggest CL is fairly valued but offers 15% upside, supported by a 'Buy' rating from most analysts.
Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can Colgate's New Productivity Program Drive Long-Term Growth?
Colgate launches a $300-$400M productivity program to boost efficiency, cut costs and fuel long-term growth amid market pressures.
Colgate-Palmolive Company (CL) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Colgate-Palmolive Company (NYSE:CL ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 9:00 AM EDT Company Participants Noel Wallace - Chairman, CEO & President Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
